<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin. Cancer Res.</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC4558226</article-id>
        <article-id pub-id-type="pmcid-ver">PMC4558226.1</article-id>
        <article-id pub-id-type="pmcaid">4558226</article-id>
        <article-id pub-id-type="pmcaiid">4558226</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS708489</article-id>
        <article-id pub-id-type="pmid">25991819</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-14-2116</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS708489</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA708489</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Braggio</surname>
              <given-names initials="E">Esteban</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Van Wier</surname>
              <given-names initials="S">Scott</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ojha</surname>
              <given-names initials="J">Juhi</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>McPhail</surname>
              <given-names initials="E">Ellen</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Asmann</surname>
              <given-names initials="YW">Yan W.</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Egan</surname>
              <given-names initials="J">Jan</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>da Silva</surname>
              <given-names initials="JA">Jackline Ayres</given-names>
            </name>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schiff</surname>
              <given-names initials="D">David</given-names>
            </name>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lopes</surname>
              <given-names initials="MB">M Beatriz</given-names>
            </name>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Decker</surname>
              <given-names initials="PA">Paul A</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Valdez</surname>
              <given-names initials="R">Riccardo</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tibes</surname>
              <given-names initials="R">Raoul</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Eckloff</surname>
              <given-names initials="B">Bruce</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Witzig</surname>
              <given-names initials="TE">Thomas E.</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Stewart</surname>
              <given-names initials="AK">A Keith</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Fonseca</surname>
              <given-names initials="R">Rafael</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Oâ€™Neill</surname>
              <given-names initials="BP">Brian Patrick</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Mayo Clinic, Scottsdale, AZ</aff>
        <aff id="A2"><label>2</label>Mayo Clinic, Rochester, MN</aff>
        <aff id="A3"><label>3</label>Mayo Clinic, Jacksonville, FL</aff>
        <aff id="A4"><label>4</label>National Institute of Cancer, Brazil</aff>
        <aff id="A5"><label>5</label>University of Virginia, Charlottesville, VA</aff>
        <author-notes>
          <corresp id="FN1"><underline>Correspondence:</underline> Esteban Braggio, PhD, Collaborative Research Building, 3-024, 400 E Shea Blvd, Scottsdale, AZ 85259-5494, (480) 301-4617/research office; (480) 301-8387/research fax; <email>braggio.esteban@mayo.edu</email></corresp>
          <fn id="FN2" fn-type="conflict">
            <p>
              <bold>Conflict of Interest Disclosures</bold>
            </p>
            <p>There are no conflicts of interest.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>19</day>
          <month>5</month>
          <year>2015</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <day>1</day>
          <month>9</month>
          <year>2015</year>
        </pub-date>
        <volume>21</volume>
        <issue>17</issue>
        <issue-id pub-id-type="pmc-issue-id">257380</issue-id>
        <fpage>3986</fpage>
        <lpage>3994</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>22</day>
              <month>07</month>
              <year>2015</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>03</day>
              <month>09</month>
              <year>2015</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>03</day>
              <month>09</month>
              <year>2015</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-05 14:06:38.133">
              <day>05</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms708489.pdf"/>
        <abstract>
          <sec id="S1">
            <title>Purpose</title>
            <p id="P1">Primary central nervous system lymphoma (PCNSL) is an aggressive non-Hodgkin lymphoma confined to the CNS. Whether there is a PCNSL-specific genomic signature and, if so, how it differs from systemic diffuse large B-cell lymphoma (DLBCL) is uncertain.</p>
          </sec>
          <sec id="S2">
            <title>Experimental design</title>
            <p id="P2">We performed a comprehensive genomic study of tumor samples from 19 immunocompetent PCNSL patients. Testing comprised array-comparative genomic hybridization and whole exome sequencing.</p>
          </sec>
          <sec id="S3">
            <title>Results</title>
            <p id="P3">Biallelic inactivation of <italic toggle="yes">TOX</italic> and <italic toggle="yes">PRKCD</italic> were recurrently found in PCNSL but not in systemic DLBCL, suggesting a specific role in PCNSL pathogenesis. Additionally, we found a high prevalence of <italic toggle="yes">MYD88</italic> mutations (79%) and <italic toggle="yes">CDKN2A</italic> biallelic loss (60%). Several genes recurrently affected in PCNSL were common with systemic DLBCL, including loss of <italic toggle="yes">TNFAIP3, PRDM1, GNA13, TMEM30A, TBL1XR1, B2M, CD58</italic>, activating mutations of <italic toggle="yes">CD79B, CARD11</italic> and translocations <italic toggle="yes">IgH-BCL6</italic>. Overall, BCR/TLR/NF-ÎºB pathways were altered in &gt;90% of PNCSL, highlighting its value for targeted therapeutic approaches. Furthermore, integrated analysis showed enrichment of pathways associated with immune response, proliferation, apoptosis, and lymphocyte differentiation.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions</title>
            <p id="P4">In summary, genome-wide analysis uncovered novel recurrent alterations, including <italic toggle="yes">TOX</italic> and <italic toggle="yes">PRKCD</italic>, helping to differentiate PCNSL from systemic DLBCL and related lymphomas.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>PCNSL</kwd>
          <kwd>array-based comparative genomic hybridization</kwd>
          <kwd>whole exome sequencing</kwd>
          <kwd>TOX</kwd>
          <kwd>PRKCD</kwd>
          <kwd>NF-kB signaling pathway</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
